Cargando…
Live-cell invasive phenotyping uncovers the ALK2/BMP6 iron homeostasis pathway as a therapeutic vulnerability in LKB1-mutant lung cancer
The acquisition of invasive properties is a prerequisite for tumor progression and metastasis. Molecular subtypes of KRAS-driven lung cancer exhibit distinct modes of invasion that likely contribute to unique growth properties and therapeutic susceptibilities. Despite this, pre-clinical discovery st...
Autores principales: | Koo, Junghui, Seong, Chang-Soo, Parker, Rebecca E., Dwivedi, Bhakti, Arthur, Robert A., Dinasarapu, Ashok Reddy, Johnston, H. Richard, Claussen, Henry, Tucker-Burden, Carol, Ramalingam, Suresh S., Fu, Haian, Zhou, Wei, Marcus, Adam I., Gilbert-Ross, Melissa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10312689/ https://www.ncbi.nlm.nih.gov/pubmed/37398244 http://dx.doi.org/10.1101/2023.06.14.544941 |
Ejemplares similares
-
Loss of the endocytic tumor suppressor HD-PTP phenocopies LKB1 and promotes RAS-driven oncogenesis
por: Seong, Chang-Soo, et al.
Publicado: (2023) -
Targeting LKB1 in cancer – exposing and exploiting vulnerabilities
por: Momcilovic, M, et al.
Publicado: (2015) -
GSK3 is required for rapalogs to induce degradation of some oncogenic proteins and to suppress cancer cell growth
por: Koo, Junghui, et al.
Publicado: (2015) -
GSK3 is required for rapalogs to induce degradation of some oncogenic proteins and to suppress cancer cell growth
por: Koo, Junghui, et al.
Publicado: (2021) -
The level of oncogenic Ras determines the malignant transformation of Lkb1 mutant tissue in vivo
por: Rackley, Briana, et al.
Publicado: (2021)